US2010016828A1PendingUtilityA1
Drug Delivery System and Method
Individually held — no corporate assignee on recordPriority: Jun 7, 1995Filed: Sep 24, 2009Published: Jan 21, 2010
Est. expiryJun 7, 2015(expired)· nominal 20-yr term from priority
A61N 1/30A61N 1/327A61N 1/0476A61N 1/0412A61K 9/127A61N 1/0428A61N 1/306A61K 9/0009
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for delivering a therapeutic agent to a predetermined location in a host is disclosed, wherein a liposome-encapsulated therapeutic agent is administered to the host, and an electrical field which encompasses a predetermined region within the host is established, such that as the liposome-encapsulated agent is exposed to the electrical field the release of the agent from the liposome to the predetermined region is enhanced.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A method for the delivery of electroporation-inducing electrical fields to a pre-determined three-dimensional space in the tissue of a patient comprising: inserting a plurality of tissue penetrating electrodes into the tissue of a patient, wherein an electrically insulative material is disposed proximate to at least a portion of at least one of said electrodes, and is of sufficient dielectric strength, to impede current flow from said portion of said electrode into the adjacent tissue; providing an electrical connection between said electrodes and an electrical pulse generating means for generating electroporation-inducing electrical fields; activating said electrical pulse generating means to transmit electrical signals to at least two of said electrodes of sufficient magnitude and duration to generate an electrical field to cause the permeabilization of cells within the pre-determined three-dimensional space, while current flow is impeded by said insulative material in tissue regions adjacent said insulative material such that the electric field in said adjacent regions is of insufficient magnitude and duration to cause the permeabilization of cells.
17 . A method according to claim 16 wherein the plurality of electrodes comprise a bipolar electrode array wherein the electrodes are placed anterior and posterior to the target tissue.
18 . A method according to claim 17 wherein the insulative material is disposed on said at least one electrode such that it impedes current flow in the tissue superior to the target tissue.
19 . A method according to claim 16 wherein the plurality of electrodes comprise at least three electrodes wherein a reference electrode is located in the center of the target tissue with satellite electrodes placed anterior and posterior to the target tissue.
20 . A method according to claim 19 wherein the insulative material is disposed on said at least one electrode such that it impedes current flow in the tissue superior to the target tissue.
21 . A method according to claim 16 wherein the plurality of electrodes comprise at least four electrodes surrounding the target tissue.
22 . A method according to claim 21 wherein the insulative material is disposed on said at least one electrode such that it impedes current flow in the tissue superior to the target tissue.
23 . A method for the delivery of a therapeutic agent to a pre-determined three-dimensional space in the tissue of a patient comprising: administering a pre-determined quantity of a therapeutic agent to the tissue of a patient; inserting a plurality of tissue penetrating electrodes into the tissue proximate the site of the administration, wherein an electrically insulative material is disposed proximate to at least a portion of at least one of said electrodes, and is of sufficient dielectric strength., to impede current flow from said portion of said electrode into the adjacent tissue; providing an electrical connection between said electrodes and an electrical pulse generating means for generating electroporation-inducing electrical fields; and activating said electrical pulse generating means to transmit electrical signals to at least two of said electrodes of sufficient magnitude and duration to generate an electrical field to cause the permeabilization of cells within the pre-determined three-dimensional space, while current flow is impeded by said insulative material in tissue regions adjacent said insulative material such that the electric field in said adjacent regions is of insufficient magnitude and duration to cause the permeabilization of cells.
24 . A method according to claim 23 wherein the plurality of electrodes comprise a bipolar electrode array wherein the electrodes are placed anterior and posterior to the target tissue.
25 . A method according to claim 24 wherein the insulative material is disposed on said at least one electrode such that it impedes current flow in the tissue superior to the target tissue.
26 . A method according to claim 23 wherein the plurality of electrodes comprise at least three electrodes wherein a reference electrode is located in the center of the target tissue with satellite electrodes placed anterior and posterior to the target tissue.
27 . A method according to claim 26 wherein the insulative material is disposed on said at least one electrode such that it impedes current flow in the tissue superior to the target tissue.
28 . A method according to claim 23 wherein the plurality of electrodes comprise at least four electrodes surrounding the target tissue.
29 . A method according to claim 28 wherein the insulative material is disposed on said at least one electrode such that it impedes current flow in the tissue superior to the target tissue.Join the waitlist — get patent alerts
Track US2010016828A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.